HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

K C Kaehler Selected Research

Immunotherapy

7/2011Sorafenib and pegylated interferon-α2b in advanced metastatic melanoma: a multicenter phase II DeCOG trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


K C Kaehler Research Topics

Disease

3Melanoma (Melanoma, Malignant)
10/2011 - 04/2008
1Renal Cell Carcinoma (Grawitz Tumor)
07/2011
1Hemorrhage
07/2011
1Neoplasm Metastasis (Metastasis)
04/2008

Drug/Important Bio-Agent (IBA)

1InterferonsIBA
07/2011
1Sorafenib (BAY 43-9006)FDA Link
07/2011
1Temozolomide (Temodar)FDA LinkGeneric
04/2008
1peginterferon alfa-2b (Pegintron)FDA Link
04/2008

Therapy/Procedure

1Lymph Node Excision (Lymph Node Dissection)
10/2011
1Immunotherapy
07/2011
1Therapeutics
07/2011
1Drug Therapy (Chemotherapy)
04/2008